BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen YR, Yan X, Yuan FZ, Ye J, Xu BB, Zhou ZX, Mao ZM, Guan J, Song YF, Sun ZW, Wang XJ, Chen ZY, Wang DY, Fan BS, Yang M, Song ST, Jiang D, Yu JK. The Use of Peripheral Blood-Derived Stem Cells for Cartilage Repair and Regeneration In Vivo: A Review. Front Pharmacol. 2020;11:404. [PMID: 32308625 DOI: 10.3389/fphar.2020.00404] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Yang M, Zhang Z, Yuan F, Deng R, Yan X, Mao F, Chen Y, Lu H, Yu J. An immunomodulatory polypeptide hydrogel for osteochondral defect repair. Bioactive Materials 2023;19:678-89. [DOI: 10.1016/j.bioactmat.2022.05.008] [Reference Citation Analysis]
2 Urlić I, Ivković A. Cell Sources for Cartilage Repair-Biological and Clinical Perspective. Cells 2021;10:2496. [PMID: 34572145 DOI: 10.3390/cells10092496] [Reference Citation Analysis]
3 Prajwal GS, Jeyaraman N, Kanth V K, Jeyaraman M, Muthu S, Rajendran SNS, Rajendran RL, Khanna M, Oh EJ, Choi KY, Chung HY, Ahn BC, Gangadaran P. Lineage Differentiation Potential of Different Sources of Mesenchymal Stem Cells for Osteoarthritis Knee. Pharmaceuticals (Basel) 2022;15:386. [PMID: 35455383 DOI: 10.3390/ph15040386] [Reference Citation Analysis]
4 Muthu S, Jeyaraman M, Jain R, Gulati A, Jeyaraman N, Prajwal GS, Mishra PC. Accentuating the sources of mesenchymal stem cells as cellular therapy for osteoarthritis knees-a panoramic review. Stem Cell Investig 2021;8:13. [PMID: 34386542 DOI: 10.21037/sci-2020-055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
5 Papadopoulos KI, Turajane T. Erratum: Commentary: Autologous Peripheral Blood Stem Cells (PBSC) are Safe and Effective in Knee Osteoarthritis. Front Pharmacol 2021;12:652738. [PMID: 33959019 DOI: 10.3389/fphar.2021.652738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang SY, Xu HH, Xiao MM, Zhang JJ, Mao Q, He BJ, Tong PJ. Subchondral bone as a novel target for regenerative therapy of osteochondritis dissecans: A case report. World J Clin Cases 2021;9:3623-30. [PMID: 34046461 DOI: 10.12998/wjcc.v9.i15.3623] [Reference Citation Analysis]
7 Chahla J, Gursoy S. Editorial Commentary: Peripheral Blood Stem Cells Mobilization Using Granulocyte Colony-Stimulating Factor for Articular Cartilage Injuries: Wake Them Up and Make Them Come to You! Arthroscopy 2021;37:2518-20. [PMID: 33745936 DOI: 10.1016/j.arthro.2021.03.026] [Reference Citation Analysis]
8 Peláez P, Damiá E, Torres-Torrillas M, Chicharro D, Cuervo B, Miguel L, Del Romero A, Carrillo JM, Sopena JJ, Rubio M. Cell and Cell Free Therapies in Osteoarthritis. Biomedicines 2021;9:1726. [PMID: 34829953 DOI: 10.3390/biomedicines9111726] [Reference Citation Analysis]
9 Papadopoulos KI, Paisan M, Sutheesophon W, Turajane T. Regarding "Mobilized Peripheral Blood Stem Cells are Pluripotent and Can be Safely Harvested and Stored for Cartilage Repair". Arthroscopy 2021;37:3389-90. [PMID: 34863374 DOI: 10.1016/j.arthro.2021.09.019] [Reference Citation Analysis]
10 Papadopoulos KI, Paisan M, Sutheesophon W, Turajane T. Novel Use of Intraarticular Granulocyte Colony Stimulating Factor (hG-CSF) Combined with Activated Autologous Peripheral Blood Stem Cells Mobilized with Systemic hG-CSF: Safe and Efficient in Early Osteoarthritis. Cartilage 2021;13:1671S-4S. [PMID: 34636658 DOI: 10.1177/19476035211049562] [Reference Citation Analysis]